Reported Sep 2, 2026 · Ongoing · Updated Sep 16, 2026
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b)…
Accord Healthcare, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: ACCORD HEALTHCARE, INC. · 8041 Arco Corporate Dr Ste 200 · Raleigh, NC · 27617-2010
Is this the product you have?
- Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only
- Manufactured forAccord Healthcare, Inc., Raleigh, NC 27617
- Manufactured byIntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India
- Lot codes and dates
a) Lot #: D2402642Exp. Date 11/30/2026 b) Lot #: D2401832Exp. Date 08/31/2026D2402525D2402527D2402526D2402644D2402643Exp. Date 11/30/2026
This recall covers 12 products
The agency filed one notice per product. You are reading one of them; the other 11 are below.
Where it was sold
- Nationwide
Why it was recalled
Subpotent Drug
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Accord Healthcare, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.